Skip to main content
. Author manuscript; available in PMC: 2022 Apr 18.
Published in final edited form as: IEEE Trans Biomed Eng. 2022 Mar 18;69(4):1449–1460. doi: 10.1109/TBME.2021.3119280

Fig. 3.

Fig. 3.

Longitudinal changes in CAM tumors. A) Representative baseline contrast-enhanced power Doppler and super-resolution ULM images of CAM engrafted tumors. B) This same control tumor at endpoint imaging, which demonstrates both the growth of the tumor diameter and the continued development of intratumor vascularization over the course of the study. Tumor outlines and maximal diameter are demonstrated as cyan and orange lines on the B-mode image, respectively. C) Quantification of the tumor long-axis which reveals a general trend of tumor growth for all treatment groups in this study. D) Quantification of the contrast power of the tumor cross-sectional area.